NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 1 filers reported holding NEVRO CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812,372 | -16.5% | 42,267 | +10.4% | 0.01% | -16.7% |
| Q2 2023 | $972,849 | -36.7% | 38,271 | -10.0% | 0.01% | -33.3% |
| Q1 2023 | $1,536,411 | -5.2% | 42,501 | +3.8% | 0.01% | 0.0% |
| Q4 2022 | $1,621,026 | -36.7% | 40,935 | -25.5% | 0.01% | -30.8% |
| Q3 2022 | $2,559,000 | +6.5% | 54,915 | +0.2% | 0.01% | +30.0% |
| Q2 2022 | $2,402,000 | -31.9% | 54,810 | +12.5% | 0.01% | -28.6% |
| Q1 2022 | $3,525,000 | +17.2% | 48,735 | +31.4% | 0.01% | -17.6% |
| Q4 2021 | $3,007,000 | -20.1% | 37,092 | +14.7% | 0.02% | -19.0% |
| Q3 2021 | $3,763,000 | -34.7% | 32,334 | -7.0% | 0.02% | -43.2% |
| Q2 2021 | $5,765,000 | – | 34,773 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |